Health Effects of Per- and Polyfluoroalkyl Substances

Marcus Cervantes, MD, MPH
Robert M. Gerbo, MD

American Family Physician. 2025;111(5):460-462.

Author disclosure: No relevant financial relationships.

CASE SCENARIO

K.H. is a 46-year-old man who presents to my clinic for evaluation of a painless testicular mass he first noticed a few weeks ago while showering. He is otherwise asymptomatic, including no fevers or penile discharge. He has a history of hyperlipidemia but no history of cancer. On physical examination, there is a 3-cm, nontender, firm mass on the right testicle. The left testicle appears normal, and there is no lymphadenopathy or abdominal mass. While discussing your concerns regarding malignancy and the need for further diagnostics, K.H. asks whether his occupation as a firefighter could be somehow related. He is currently employed as a civilian firefighter; during his previous military service as a firefighter, he reports extensive use of aqueous film-forming foams that contained per- and polyfluoroalkyl substances (PFAS) when extinguishing airport and military installation fires. In addition to treating my patient, how can I best answer his question about the relevance of PFAS in causing his condition?

COMMENTARY

PFAS are a class of chemicals that are widely used in industry and commonly found in the environment. There are thousands of different PFAS, but some have been studied more comprehensively than others (eg, perfluorooctanoic acid, perfluorooctanesulfonic acid, perfluorohexanesulfonic acid, perfluorodecanoic acid, perfluorononanoic acid). Of these, perfluorooctanoic acid and perfluorooctanesulfonic acid are more common in industrial use, although less often now because of industrial phaseout or regulation against their use worldwide.1

PFAS are primarily used as fluorosurfactants; they are included in several consumer products such as nonstick cookware and stain-, wrinkle-, and water-resistant fabrics.2 The unique property of PFAS to resist oil and water makes them a key component in aqueous film-forming foams and, thus, an excellent firefighting tool when addressing petroleum-based fires.3 These foams have been in use since the 1970s but are currently planned for phaseout by the US Department of Defense.

PFAS are highly concerning to environmental regulators because of their prevalence in water due to their water solubility. They are also extremely long lasting, receiving the nickname forever chemicals. Within the United States alone, PFAS have been detected in nearly 50% of all tap water, and they are widely used outside of the United States, making them a significant cause for global concern.4

Health Effects

The Agency for Toxic Substances and Disease Registry has a toxicologic profile for PFAS.5 The Centers for Disease Control and Prevention also has included data on PFAS since 1999 in the National Health and Nutrition Examination Survey.6 Based on these and other observational data, sufficient evidence supports association between PFAS and decreased antibody response after vaccination or infection, elevated risk for dyslipidemia, decreased infant and fetal growth, and heightened risk of kidney cancers in adults.3 Evidence suggests associations between PFAS and increased risk of liver and thyroid dysfunction.5 Other cancers, including breast and testicular, may be linked to PFAS.7 Suggestive evidence also supports an elevated risk of ulcerative colitis in adults.3

Some literature has described other adverse health effects, although according to current Agency for Toxic Substances and Disease Registry recommendations, there is insufficient evidence to suggest that this is the case.5 These effects include infertility, metabolic syndrome, obesity, and reproductive effects. Associations also include cancers other than kidney, breast, and testicular; however, considerable gaps are found in current research.3 Most research focused on PFAS has concentrated on a limited number of compounds (eg, perfluorooctanoic acid, perfluorooctanesulfonic acid), leaving more than a thousand others unstudied or understudied to determine their toxicity and possible adverse health effects.

MARCUS CERVANTES, MD, MPH, School of Public Health, Occupational and Environmental Medicine, Occupational Medicine, West Virginia University, Morgantown

ROBERT M. GERBO, MD, School of Public Health, Occupational Medicine, Faculty Athletics, West Virginia University, Morgantown

Address correspondence to Marcus Cervantes, MD, MPH, at Marcus.Cervantes@hsc.wvu.edu.

Author disclosure: No relevant financial relationships.

  1. 1.Sinclair GM, Long SM, Jones OAH. What are the effects of PFAS exposure at environmentally relevant concentrations? Chemosphere. 2020;258:127340.
  2. 2.Glüge J, Scheringer M, Cousins IT, et al. An overview of the uses of per- and polyfluoroalkyl substances (PFAS). Environ Sci Process Impacts. 2020;22(12):2345-2373.
  3. 3.National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Division on Earth and Life Studies; Board on Population Health and Public Health Practice; Board on Environmental Studies and Toxicology; Committee on the Guidance on PFAS Testing and Health Outcomes. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. National Academies Press; 2022.
  4. 4.Smalling KL, Romanok KM, Bradley PM, et al. Per- and polyfluoroalkyl substances (PFAS) in United States tapwater: comparison of underserved private-well and public-supply exposures and associated health implications. Environ Int. 2023;178:108033.
  5. 5.U.S. Department of Health and Human Services; Agency for Toxic Substances and Disease Registry. Toxicological profile for perfluoroalkyls; May 2021. Accessed March 19, 2025. https://www.atsdr.cdc.gov/toxprofiles/tp200.pdf
  6. 6.Botelho JC, Kato K, Wong LY, et al. Per- and polyfluoroalkyl substances (PFAS) exposure in the U.S. population: NHANES 1999–March 2020. Environ Res. 2025;270:120916.
  7. 7.Purdue MP, Rhee J, Denic-Roberts H, et al. A nested case-control study of serum per- and polyfluoroalkyl substances and testicular germ cell tumors among U.S. Air Force servicemen. Environ Health Perspect. 2023;131(7):77007.
  8. 8.Lewis RC, Johns LE, Meeker JD. Serum biomarkers of exposure to perfluoroalkyl substances in relation to serum testosterone and measures of thyroid function among adults and adolescents from NHANES 2011–2012. Int J Environ Res Public Health. 2015;12(6):6098-6114.
  9. 9.Rosato I, Bonato T, Fletcher T, et al. Estimation of per- and polyfluoroalkyl substances (PFAS) half-lives in human studies: a systematic review and meta-analysis. Environ Res. 2024;242:117743.
  10. 10.Sunderland EM, Hu XC, Dassuncao C, et al. A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects. J Expo Sci Environ Epidemiol. 2019;29(2):131-147.
  11. 11.Rogers RD, Reh CM, Breysse P. Advancing per- and polyfluoroalkyl substances (PFAS) research: an overview of ATSDR and NCEH activities and recommendations. J Expo Sci Environ Epidemiol. 2021;31(6):961-971.
  12. 12.Sonnenberg NK, Ojewole AE, Ojewole CO, et al. Trends in serum perand polyfluoroalkyl substance (PFAS) concentrations in teenagers and adults, 1999–2018 NHANES. Int J Environ Res Public Health. 2023;20(21):6984.
  13. 13.Jalilian H, Ziaei M, Weiderpass E, et al. Cancer incidence and mortality among firefighters. Int J Cancer. 2019;145(10):2639-2646.

Case scenarios are written to express typical situations that family physicians may encounter; authors remain anonymous. Send scenarios to afpjournal@aafp.org. Materials are edited to retain confidentiality.

This series is coordinated by Caroline Wellbery, MD, associate deputy editor.

A collection of Curbside Consultation published in AFP is available at https://www.aafp.org/afp/curbside.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.